NO157504C - Analogifremgangsmaate til fremstilling av hydroksyamino-alkan- eller -alken-fosfonsyrederivater med antimikrobiell virkning. - Google Patents

Analogifremgangsmaate til fremstilling av hydroksyamino-alkan- eller -alken-fosfonsyrederivater med antimikrobiell virkning.

Info

Publication number
NO157504C
NO157504C NO772652A NO772652A NO157504C NO 157504 C NO157504 C NO 157504C NO 772652 A NO772652 A NO 772652A NO 772652 A NO772652 A NO 772652A NO 157504 C NO157504 C NO 157504C
Authority
NO
Norway
Prior art keywords
alken
hydroxyamino
alkane
preparation
acid derivatives
Prior art date
Application number
NO772652A
Other languages
English (en)
Norwegian (no)
Other versions
NO772652L (no
NO157504B (no
Inventor
Yoshio Kuroda
Masakuni Okuhara
Eiko Iguchi
Hatsuo Aoki
Hiroshi Imanaka
Takashi Kamiya
Masashi Hashimoto
Keiji Hemmi
Hidekazu Takeno
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Publication of NO772652L publication Critical patent/NO772652L/no
Publication of NO157504B publication Critical patent/NO157504B/no
Publication of NO157504C publication Critical patent/NO157504C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40Esters thereof
    • C07F9/4003Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4006Esters of acyclic acids which can have further substituents on alkyl
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3808Acyclic saturated acids which can have further substituents on alkyl
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3826Acyclic unsaturated acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Cephalosporin Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO772652A 1976-07-27 1977-07-26 Analogifremgangsmaate til fremstilling av hydroksyamino-alkan- eller -alken-fosfonsyrederivater med antimikrobiell virkning. NO157504C (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB3133976 1976-07-27
GB4222276 1976-10-11
GB31339/76A GB1580899A (en) 1976-07-27 1977-06-20 Hydroxyaminohydrocarbonphosphonic acid derivatives and production and use thereof

Publications (3)

Publication Number Publication Date
NO772652L NO772652L (no) 1978-01-30
NO157504B NO157504B (no) 1987-12-21
NO157504C true NO157504C (no) 1988-03-30

Family

ID=27258468

Family Applications (1)

Application Number Title Priority Date Filing Date
NO772652A NO157504C (no) 1976-07-27 1977-07-26 Analogifremgangsmaate til fremstilling av hydroksyamino-alkan- eller -alken-fosfonsyrederivater med antimikrobiell virkning.

Country Status (21)

Country Link
US (1) US4182758A (es)
JP (1) JPS5340720A (es)
AR (1) AR226522A1 (es)
AT (2) AT367064B (es)
CA (1) CA1091241A (es)
CH (5) CH640862A5 (es)
DE (2) DE2760320C2 (es)
DK (1) DK149609C (es)
ES (3) ES461084A1 (es)
FI (1) FI64377C (es)
FR (1) FR2474505A1 (es)
GB (1) GB1580899A (es)
GR (1) GR61140B (es)
HU (1) HU182023B (es)
IE (1) IE45536B1 (es)
NL (1) NL7708325A (es)
NO (1) NO157504C (es)
OA (1) OA05725A (es)
PH (1) PH14401A (es)
PT (1) PT66854B (es)
SE (1) SE441360B (es)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4084953A (en) * 1977-03-09 1978-04-18 Monsanto Company N-hydroxy-N-phosphonomethylglycines and the herbicidal use thereof
US4210635A (en) * 1978-02-15 1980-07-01 Fujisawa Pharmaceutical Co., Ltd. Antibacterial composition
US4268503A (en) * 1978-09-14 1981-05-19 Fujisawa Pharmaceutical Co., Ltd. Antibacterial composition
US4693742A (en) * 1983-12-20 1987-09-15 Rohm And Hass Company Herbicidal hydroxyamino phosphonic acids and derivatives
US5189030A (en) * 1985-06-11 1993-02-23 Ciba-Geigy Corporation 1-amino-2-phenylethanephosphonic acids as microbiocides
JPH0340299U (es) * 1989-08-31 1991-04-18
DE19843223A1 (de) * 1998-09-22 2000-03-30 Hassan Jomaa Phosphororganische Verbindungen und ihre Verwendung
DE19825585A1 (de) * 1998-04-14 1999-10-21 Hassan Jomaa Verwendung von Aminohydrocarbylphosphonsäurederivaten zur therapeutischen und prophylaktischen Behandlung von Infektionen, die durch Parasiten, Pilze oder Viren hervorgerufen werden
CN1297352A (zh) 1998-04-14 2001-05-30 哈桑·朱马 有机磷化合物在治疗和预防性治疗感染中的应用
CA2336143A1 (en) 1998-07-15 2000-01-27 Hassan Jomaa Aminoalkylphosphonic acid derivatives and their use in treating infections
US6753324B2 (en) 1998-07-15 2004-06-22 Hassan Jomaa Phosphorous organic compounds and their use
WO2000003699A2 (de) * 1998-07-15 2000-01-27 Jomaa Hassan Arzneimittel mit einem gehalt an phosphonsäurederivaten als wirkstoff und ihre verwendung
DE19854403A1 (de) * 1998-11-25 2000-05-31 Hassan Jomaa Phosphororganische Verbindungen und ihre Verwendung
WO2001060829A1 (de) * 2000-02-18 2001-08-23 Jomaa Pharmaka Gmbh Phosphororganische verbindungen und ihre verwendung
DE10035189A1 (de) * 2000-07-20 2002-02-21 Hassan Jomaa Arzneimittel zur oralen Applikation mit einem Gehalt an 3-N-Formylhydroxylaminopropylphosphonsäureestern oder 3-N-Acetylhydroxylaminopropylphosphonsäureestern als Wirkstoff
WO2007039635A2 (en) * 2005-10-06 2007-04-12 Innate Pharma Phosphoantigen salts of organic bases and methods for their crystallization
US8258302B2 (en) * 2006-01-31 2012-09-04 Api Corporation Method for producing benzazepinone
US8580859B2 (en) 2008-08-01 2013-11-12 Bioxiness Pharmaceuticals, Inc. Methionine analogs and methods of using same
EP2404601A1 (en) 2010-07-06 2012-01-11 BioAgency AG New drug combinations for the treatment of Malaria
EP2725029A1 (en) * 2012-10-29 2014-04-30 Laboratoire Biodim New antibacterial compounds and biological applications thereof
US20210261580A1 (en) * 2018-06-18 2021-08-26 The George Washington University, A Congressionally Chartered Not-For-Profi1 Antibiotics for veterinary staphylococcal infections
US20220401462A1 (en) 2019-10-19 2022-12-22 Dmg Deutsche Malaria Gmbh Combination preparations of 3-n-formylhydroxylaminopropyl phosphonic acid derivatives or 3-n-acetylhydroxylaminopropyl phosphonic acid derivatives with clindamycin and artesunate
EP3960176A1 (en) 2020-08-26 2022-03-02 DMG Deutsche Malaria GmbH Piperaquine and related drug combinations for use in the treatment of covid-19

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL6905272A (es) 1968-05-15 1969-11-18
US3764677A (en) * 1971-06-25 1973-10-09 Gates Rubber Co Diethyl betaaminoethylphosphonate as an antimicrobial agent

Also Published As

Publication number Publication date
AT367430B (de) 1982-07-12
ATA550977A (de) 1981-10-15
DE2733658A1 (de) 1978-02-09
SE441360B (sv) 1985-09-30
DK149609B (da) 1986-08-11
US4182758A (en) 1980-01-08
FI64377C (fi) 1983-11-10
ATA564879A (de) 1981-11-15
PH14401A (en) 1981-06-25
GB1580899A (en) 1980-12-10
SE7708592L (sv) 1978-01-28
CH647807A5 (de) 1985-02-15
JPS5340720A (en) 1978-04-13
ES461084A1 (es) 1978-12-01
ES471822A1 (es) 1979-10-16
NL7708325A (nl) 1978-01-31
DK337877A (da) 1978-01-28
FR2474505A1 (fr) 1981-07-31
NO772652L (no) 1978-01-30
ES479211A1 (es) 1979-12-16
AT367064B (de) 1982-05-25
HU182023B (en) 1983-12-28
IE45536B1 (en) 1982-09-22
CH646978A5 (de) 1984-12-28
CH646980A5 (de) 1984-12-28
JPS613799B2 (es) 1986-02-04
DK149609C (da) 1987-02-09
CA1091241A (en) 1980-12-09
CH646979A5 (de) 1984-12-28
GR61140B (en) 1978-09-23
PT66854B (en) 1978-12-28
FI64377B (fi) 1983-07-29
NO157504B (no) 1987-12-21
FI772280A (es) 1978-01-28
OA05725A (fr) 1981-05-31
AR226522A1 (es) 1982-07-30
CH640862A5 (de) 1984-01-31
FR2474505B1 (es) 1984-01-27
DE2760320C2 (es) 1988-11-03
IE45536L (en) 1978-01-27
PT66854A (en) 1977-08-01
DE2733658C2 (es) 1987-06-25

Similar Documents

Publication Publication Date Title
NO157504C (no) Analogifremgangsmaate til fremstilling av hydroksyamino-alkan- eller -alken-fosfonsyrederivater med antimikrobiell virkning.
NO152935C (no) Analogifremgangsmaate for fremstilling av anti-inflammatorisk virksomme tioetiansyrederivater.
SE435059B (sv) Forfarande for framstellning av med kveveheterocykliska grupper substituerade 1-fenyl-2-alkylaminoetanol-foreningar
NO156611C (no) Analogifremgangsmaate for fremstilling av terapeutiske virksomme derivater av hydroksykarbonylfosfonsyre.
NO770366L (no) Fremgangsm}te for fremstilling av meta-aryloksy-benzaldehyder.
SE420314B (sv) Analogiforfarande for framstellning av indolizinderivat
NO151365C (no) Fremgangsmaate for fremstilling av 4-halogen-dihydropyran-derivater.
SE7504842L (sv) Forfarande for framstellning av adeninderivat..
NO147716C (no) Analogifremgangsmaate for fremstilling av antibakterielle erytromycylaminderivater.
SE436026B (sv) Forfarande for framstellning av 13,14-dehydroprostaglandiner
NO148291C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive basisk substituerte teofyllinderivater
NO771870L (no) Fremgangsm}te for fremstilling av 3,4-dihydro-2-metyl-4-okso-2h-1,2-benzotiazin-3-karboksylsyre-1,1-dioksyd
NO147600C (no) Fremgangsmaate til fremstilling av tereftalsyre.
NO152451C (no) Fremgangsmaate for fremstilling av fosfonsyrederivater
SE7601605L (sv) Forfarande for framstellning av 1 alfa,25-dihydroxi-cholkalciferol
SE435380B (sv) Forfarande for framstellning av kinazolinforeningar
NO145234C (no) Fremgangsmaate for fremstilling av alfa-cyano-benzyl-karboksylat-estere.
SE419083B (sv) Analogiforfarande for framstellning av nikotinoylamino-triazinderivat
NO147024C (no) Fremgangsmaate til fremstilling av sterisk hindrede bis- eller polyfenoler.
DK145930C (da) Fremgangsmaade til fremstilling af 2-substituerede 1,4-benzodiazepinderivater eller syreadditionssalte deraf
SE7700572L (sv) Forfarande for framstellning av tienopyridinderivat
SE436496B (sv) Forfarande for framstellning av dibensotiofenderivat
NO774147L (no) Fremgangsmaate for fremstilling av kinazolinonforbindelser
NO161261C (no) Analogifremgangsmaate for fremstilling av 4-karbamoyloksyoksazafosforinderivater med cytostatisk virkning.
SE7711347L (sv) Analogiforfarande for framstellning av n-6-kloronikotinoyl-d,1-homocysteintiolakton